Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.

Aperçu de l'étude

Statut

Inconnue

Les conditions

Description détaillée

The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.

Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.

Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .

Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.

Type d'étude

Interventionnel

Inscription (Anticipé)

80

Phase

  • Phase 4

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Zhejiang
      • Hangzhou, Zhejiang, Chine, 310009
        • Recrutement
        • The Second Affiliated Hospital Zhejiang University School of Medicine
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 70 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
  • Age ≧ 18 years old, ≦70 years old
  • Temperature, white blood cells, and hemoglobin were normal before surgery
  • Patient informed consent

Exclusion Criteria:

  • Patients with a history of surgery within six months
  • Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
  • American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
  • Allergic to lidocaine
  • Bradycardia (heart rate < 60 beats/min) or atrioventricular block
  • Mental disorder
  • Patients requiring a right double lumen bronchial catheter

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
Comparateur placebo: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
IV bolus of saline, followed by continuous infusion of saline

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Postoperative pain score
Délai: Immediately postoperation
Using Visual Analogue Scales
Immediately postoperation
Postoperative pain score
Délai: 1 hour postoperation
Using Visual Analogue Scales
1 hour postoperation
Postoperative pain score
Délai: 4 hours postoperation
Using Visual Analogue Scales
4 hours postoperation
Postoperative pain score
Délai: 8 hours postoperation
Using Visual Analogue Scales
8 hours postoperation
Postoperative pain score
Délai: 24 hours postoperation
Using Visual Analogue Scales
24 hours postoperation
Postoperative pain score
Délai: 48 hours postoperation
Using Visual Analogue Scales
48 hours postoperation

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Opioid requirement
Délai: Immediately postoperation
The dosage of opioids was recorded
Immediately postoperation
Opioid requirement
Délai: 1 hour postoperation
The dosage of opioids was recorded
1 hour postoperation
Opioid requirement
Délai: 4 hours postoperation
The dosage of opioids was recorded
4 hours postoperation
Opioid requirement
Délai: 8 hours postoperation
The dosage of opioids was recorded
8 hours postoperation
Opioid requirement
Délai: 24 hours postoperation
The dosage of opioids was recorded
24 hours postoperation
Opioid requirement
Délai: 48 hours postoperation
The dosage of opioids was recorded
48 hours postoperation
Pressing times of PCIA postoperation
Délai: 48 hours postoperation
The pressing times of PCIA within 48 hours postoperation was recorded
48 hours postoperation
Occurrence of nausea and/or vomiting
Délai: 48 hours postoperation
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
48 hours postoperation
Blood level of adrenaline
Délai: before induction
Perioperative blood level of adrenaline was recorded
before induction
Blood level of adrenaline
Délai: after incision
Perioperative blood level of adrenaline was recorded
after incision
Blood level of adrenaline
Délai: immediately after extubation
Perioperative blood level of adrenaline was recorded
immediately after extubation
Blood level of norepinephrine
Délai: before induction
Perioperative blood level of norepinephrine was recorded
before induction
Blood level of norepinephrine
Délai: after incision
Perioperative blood level of norepinephrine was recorded
after incision
Blood level of norepinephrine
Délai: immediately after extubation
Perioperative blood level of norepinephrine was recorded
immediately after extubation
Blood level of adrenocortical
Délai: before induction
Perioperative blood level of adrenocortical was recorded
before induction
Blood level of adrenocortical
Délai: after incision
Perioperative blood level of adrenocortical was recorded
after incision
Blood level of adrenocortical
Délai: immediately after extubation
Perioperative blood level of adrenocortical was recorded
immediately after extubation
Blood level of TNF-alpha
Délai: before induction
Perioperative blood level of TNF-alpha was recorded
before induction
Blood level of TNF-alpha
Délai: after incision
Perioperative blood level of TNF-alpha was recorded
after incision
Blood level of TNF-alpha
Délai: immediately after extubation
Perioperative blood level of TNF-alpha was recorded
immediately after extubation
Blood level of IL-6
Délai: before induction
Perioperative blood level of IL-6 was recorded
before induction
Blood level of IL-6
Délai: after incision
Perioperative blood level of IL-6 was recorded
after incision
Blood level of IL-6
Délai: immediately after extubation
Perioperative blood level of IL-6 was recorded
immediately after extubation
Blood level of IL-10
Délai: before induction
Perioperative blood level of IL-10 was recorded
before induction
Blood level of IL-10
Délai: after incision
Perioperative blood level of IL-10 was recorded
after incision
Blood level of IL-10
Délai: immediately after extubation
Perioperative blood level of IL-10 was recorded
immediately after extubation
Duration of hospital stay
Délai: from day of surgery until day of discharge from hospital
length of hospital stay (in days)
from day of surgery until day of discharge from hospital

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chaise d'étude: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Anticipé)

1 août 2019

Achèvement primaire (Anticipé)

31 décembre 2019

Achèvement de l'étude (Anticipé)

31 décembre 2020

Dates d'inscription aux études

Première soumission

19 juillet 2019

Première soumission répondant aux critères de contrôle qualité

31 juillet 2019

Première publication (Réel)

2 août 2019

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

2 août 2019

Dernière mise à jour soumise répondant aux critères de contrôle qualité

31 juillet 2019

Dernière vérification

1 juillet 2019

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner